Oral Versus Long Acting Injectable Antipsychotics Of Schizophrenia And Special Populations At Risk For Treatment
Zhornitsky, S., & Stip, E. (2012). Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review. Schizophrenia Research and Treatment, 2012, 1-12. doi:10.1155/2012/407171
2. Summary of the article in your own words—500 words or less; (do not copy the abstract):
Antipsychotic medication nonaderence is a popular topic when discussing about patients with severe mental illness (SMI) such as schizophrenia and interventions that health care organization can incorporate into their system for quality improvement to combat the problem. The primary purpose of the article is to compare the efficacy between oral medications versus long-acting injection, as there are contradictory research outcome.
Schizophrenia is a chronic psychiatric illness that have debilitating outcome that negatively impact an individual’s cognitive capacity and social skills. The symptoms include both positive (hallucinations, delusions) and negative (poor insight, anhedonia) symptoms. The disease is synonymous with relapse exacerbation related to antipsychotic medication nonadherence, and its ability to lower functional level with each episode.
Antipsychotic medication is proven to be an effective intervention to treat the disease, especially if the patient is in their first episodic psychosis (FEP).…